Comparison of CGM data between iPro2 and Libre Pro.

Comparison of CGM data between iPro2 and Libre Pro. - Comparison of CGM data between iPro2 and Libre Pro.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027263

Enrollment

Registered

2017-05-07

Start date

2017-05-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus patients

Interventions

iPro 2 and Libre Pro

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diabetes mellitus patients under treatment.

Exclusion criteria

Exclusion criteria: Nothing

Design outcomes

Primary

Measure	Time frame
Correlation between CGM data obtained by iPro2 or Libre Pro and blood glucose levels by self-monitoring blood glucose.	—

Secondary

Measure	Time frame
Mean, maximum, and minimum glucose levels, and SD of glucose levels	—

Countries

Japan

Contacts

Public ContactTakahiro Yajima

Matsunami general hospital Department of Nephrology

yajima5639@gmail.com058-388-0111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026